Validation of a motion‐robust 2D sequential technique for quantification of hepatic proton density fat fraction during free breathing
- 17 April 2018
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 48 (6) , 1578-1585
Abstract
Background: Current chemical‐shift‐encoded (CSE) MRI techniques for measuring hepatic proton density fat fraction (PDFF) are sensitive to motion artifacts.Purpose: Initial validation of a motion‐robust 2D‐sequential CSE‐MRI technique for quantification of hepatic PDFF.Study Type: Phantom study and prospective in vivo cohort.Population: Fifty adult patients (27 women, 23 men, mean age 57.2 years).Field Strength/Sequence: 3D, 2D‐interleaved, and 2D‐sequential CSE‐MRI acquisitions at 1.5T.Assessment: Three CSE‐MRI techniques (3D, 2D‐interleaved, 2D‐sequential) were performed in a PDFF phantom and in vivo. Reference standards were 3D CSE‐MRI PDFF measurements for the phantom study and single‐voxel MR spectroscopy hepatic PDFF measurements (MRS‐PDFF) in vivo. In vivo hepatic MRI‐PDFF measurements were performed during a single breath‐hold (BH) and free breathing (FB), and were repeated by a second reader for the FB 2D‐sequential sequence to assess interreader variability.Statistical Tests: Correlation plots to validate the 2D‐sequential CSE‐MRI against the phantom and in vivo reference standards. Bland–Altman analysis of FB versus BH CSE‐MRI acquisitions to evaluate robustness to motion. Bland–Altman analysis to assess interreader variability.Results: Phantom 2D‐sequential CSE‐MRI PDFF measurements demonstrated excellent agreement and correlation (R2 > 0.99) with 3D CSE‐MRI. In vivo, the mean (±SD) hepatic PDFF was 8.8 ± 8.7% (range 0.6–28.5%). Compared with BH acquisitions, FB hepatic PDFF measurements demonstrated bias of +0.15% for 2D‐sequential compared with + 0.53% for 3D and +0.94% for 2D‐interleaved. 95% limits of agreement (LOA) were narrower for 2D‐sequential (±0.99%), compared with 3D (±3.72%) and 2D‐interleaved (±3.10%). All CSE‐MRI techniques had excellent correlation with MRS (R2 > 0.97). The FB 2D‐sequential acquisition demonstrated little interreader variability, with mean bias of +0.07% and 95% LOA of ± 1.53%.Data Conclusion: This motion‐robust 2D‐sequential CSE‐MRI can accurately measure hepatic PDFF during free breathing in a patient population with a range of PDFF values of 0.6–28.5%, permitting accurate quantification of liver fat content without the need for suspended respiration.Level of Evidence: 1Technical Efficacy: Stage 2J. Magn. Reson. Imaging 2018;48:1578–1585Keywords
Funding Information
- National Institutes of Health (UL1TR00427, R01-DK083380, R01-DK088925, R01-DK100651, K24-DK102595)
This publication has 23 references indexed in Scilit:
- Combination of complex‐based and magnitude‐based multiecho water‐fat separation for accurate quantification of fat‐fractionMagnetic Resonance in Medicine, 2011
- In vivo characterization of the liver fat 1H MR spectrumNMR in Biomedicine, 2010
- Quantification of Hepatic Steatosis with 3-T MR Imaging: Validation inob/obMiceRadiology, 2010
- T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: Validation in a fat‐water‐SPIO phantomJournal of Magnetic Resonance Imaging, 2009
- Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantificationJournal of Magnetic Resonance Imaging, 2009
- Multiecho water‐fat separation and simultaneous R estimation with multifrequency fat spectrum modelingMagnetic Resonance in Medicine, 2008
- Fat quantification with IDEAL gradient echo imaging: Correction of bias from T1 and noiseMagnetic Resonance in Medicine, 2007
- Prevalence of Fatty Liver in Children and AdolescentsPediatrics, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999